Y-151

N/A

Report date: 2026/03/19 17:01:16

Base Information

Drug NameY-151
Drug Alias NameY-151
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionAnti-BCMAAnti-CD3
TargetsT cell surface glycoprotein CD3B-cell maturation protein
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCSPC Pharmaceutical Group LtdWuhan Yzy Medical Science And Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Yzy Medical Science And Technology Co LtdCSPC Pharmaceutical Group Ltd
Inactive CompaniesN/A
Active IndicationsLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A